GitLab Is Starting to Prove the Bears Wrong
After turning in another solid quarter, GitLab (NASDAQ: GTLB) is starting to prove the bear case wrong, and its stock is finally beginning to reflect that, with its shares climbing on its latest report.
Transport
1 Unstoppable Cryptocurrency to Buy Before It Soars 270%
Bitcoin must grow at a nearly 40% annual rate to hit a price of $300,000 by 2030.
The S&P 500's Yield Is at Historic Lows. Here Are 3 Dividend Stocks I'd Buy in September.
McDonald's has raised its dividend for 49 straight years and currently offers a forward yield of 2.89%.
Grab COO Dumps 145,000 Company Shares After the Stock's 28% One-Year Decline
The transaction involved ~145,000 shares at an execution price of $3.48 per share, representing a total value of ~$506,000.
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
The sale of 33,416 shares generated a total value of approximately $1.7 million based on a weighted average execution price of $49.85.
Prediction: SoundHound Passes $500 Million in Revenue Before It Turns a Profit
SoundHound grew second-quarter revenue 45% year over year to a record $61.9 million and now expects $230 million to $260 million for 2026.
Rocket Lab CFO Dumps Over 140,000 Company Shares Worth $8.8 Million Amid a 28% One-Year Return
The transaction involved ~140,000 shares with an estimated value of ~$8.8 million at a weighted average price of $62.63 per share on September 2, 2026.
FDA Approves Guardant360 CDx Companion Diagnostic For ESR1-Mutated Breast Cancer
(RTTNews) - Guardant Health Inc. (GH) announced that the U.S. Food and Drug Administration approved Guardant360 CDx as a companion diagnostic or CDx to identify patients with hormone receptor (HR)-positive, HER2-negativ…
This eVTOL Stock Could Set Early Investors Up for Life
Archer Aviation acquired three businesses from Boeing, one of which is developing autonomous eVTOLs.
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case.
Viking Therapeutics has significant upside potential based on Wall Street targets.
Bill Gates Says He Still Won't Invest in Crypto, Calls It a "Pure Mania-Driven Asset." Here's Why He's Right.
Microsoft co-founder Bill Gates was recently asked where he would put money if he wanted to diversify away from the U.S. dollar. His choices included gold, the euro, Chinese yuan, and cryptocurrency. Gates said he still…
Resideo SVP Mehta Buys 10,928 Shares in $226,000 Direct Purchase
Amit Ashvin Mehta, SVP, Strategy & Business Ops of Resideo Technologies (NYSE:REZI), executed a direct purchase of 10,928 shares of common stock on Aug. 17, 2026, according to a recent SEC Form 4 filing.
IonQ vs. Rigetti Computing: Which Pure-Play Quantum Pioneer Has the Stronger Technology Advantage?
In the quantum computing investment sector, two popular stock picks are IonQ (NYSE: IONQ) and Rigetti Computing (NASDAQ: RGTI). Both of these quantum computing upstarts have a long way to go before becoming a viable inv…
CVB Financial Director Mike Maddox Buys 10,000 Shares
Director Mike Maddox purchased 10,000 shares of CVB Financial(NASDAQ:CVBF) at $22.03 per share on Aug. 31, 2026, according to a SEC Form 4 filing.
Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It
Cerebras grew its second-quarter adjusted revenue 103% year over year to $209.9 million.
With AI Revenue Set to Surge 400% Over the Next 2 Years, Broadcom Stock Looks Like a Buy on Recent Dip
With its artificial intelligence (AI) revenue surging and its stock recently stuck in the mud, Broadcom (NASDAQ: AVGO) is starting to look like one of the most attractive stocks in the AI infrastructure space. The desig…
Anthropic Could Be the Next Mega IPO: 2 Magnificent Stocks That Already Own a Piece of the AI Unicorn
The hottest IPO of the year hasn't even been formally announced yet (sorry, Space Exploration Technologies).
Warren Buffett's Successor Greg Abel Spent $4.5 Billion Buying 1 Stock Last Quarter, and He Spent At Least $3.3 Billion Buying More This Quarter
Greg Abel broke two long streaks started by Warren Buffett in the last few years of his tenure as CEO.
Fed Chair Kevin Warsh Just Shifted the Central Bank's Entire Focus on Inflation in One Sentence
Fed Chair Kevin Warsh has vowed to lead a reform-oriented central bank and has, thus far, held that promise.
Ares Capital Fell Enough to Push Its Yield Near 10%. Here's the Number That Actually Worries Me.
Shares of Ares Capital (NASDAQ:ARCC) have fallen about 10% from their 52-week high ($22.51) to their current level of around $20 per share. That has pushed its dividend yield up near 10% (recently around 9.6%). Several …
This Could Drain Your Retirement Savings Faster Than a Bear Market
The right investments coupled with a strategic Social Security claim could do the trick.
Schwab Bond ETFs See Billions Pour In, and Here's Why
With billions flowing into their funds, it's been a banner year for Schwab's bond ETFs. As of August, Schwab's core bond funds have each experienced inflows of over $1 billion, with two ETFs bringing in nearly $2 billio…
The Nuclear Energy Boom: Where the Industry Really Stands Heading Into 4Q 2026
Nuclear fuel supplier Cameco reports that there are 77 nuclear reactors under construction worldwide.
I Love Bloom Energy for 1 Reason, and It's Not the Backlog
Bloom Energy (NYSE: BE), a developer of solid oxide fuel cells (SOFCs), has rallied more than 2,000% over the past two years. That rally was driven by the surging demand for its SOFCs -- which can convert natural gas, b…